Florac is a private equity firm founded in 2009 by the Meyer family, historically major shareholders of the Louis Dreyfus Group. Based in Paris, France, they focus on private equity investments predominantly across Europe and the United States. With core specialties in acquisition strategies, Florac implements control acquisition, shared control, and minority investments with board representation, involving growth capital, recapitalizations, leveraged buyouts, and management buyouts. They target sectors with reliable growth prospects and companies that already demonstrate solid profitability and competitive advantages, such as distinctive know-how, technology, branding, or market share. Florac prioritizes growth strategies over rent-seeking situations, seeking to assist ambitious strategic projects and to foster the emergence of national and international market leaders. They aim to form durable partnerships with experienced management teams and founders, lending expertise but not taking over operational management, instead focusing on strategic decision-making, support, networking, and assistance in extraordinary transactions. Florac chooses to concentrate on a limited portfolio to actively engage with each investment, as every opportunity is seen as a strategic stake with regular attention. With an evergreen structure meant for sustainable family wealth growth, they exhibit flexibility in investment configurations, terms, and duration, adapting to partner needs and investment opportunities. Local teams with international ambitions are rooted in the U.S. and France, utilizing networks to seek sector expertise for investment expansion globally. Investment criteria include no specific sector allocation, preference for Europe and the U.S., investing 20-100M euros with the ability to mobilize substantial additional resources, and flexible investment horizons. Governance is maintained by family leadership, with strategic decisions made swiftly through an Investment Committee or a Strategic Council, including independent members for expert guidance.